Cargando…
A retrospective cohort study of prescribing outcomes in outpatients treated with nirmatrelvir–Ritonavir for COVID-19 in an interdisciplinary community clinic
BACKGROUND: Large observational studies have demonstrated the real-world effectiveness of nirmatrelvir–ritonavir in preventing severe COVID-19 in higher risk individuals, but have provided limited information on other aspects of nirmatrelvir-ritonavir use. Our objective was to evaluate prescribing o...
Autores principales: | Leung, Valerie, Gill, Suzanne, Llanes, Andrea, Khawaja, Armughan, Stagg, Amanda, McCready, Janine, Jacubovich, Mariana, Ho, Grace, Powis, Jeff, Kandel, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586632/ https://www.ncbi.nlm.nih.gov/pubmed/37856531 http://dx.doi.org/10.1371/journal.pone.0293302 |
Ejemplares similares
-
Reducing co-administration of proton pump inhibitors and antibiotics using a computerized order entry alert and prospective audit and feedback
por: Kandel, Christopher E., et al.
Publicado: (2016) -
Every antibiotic, every day: Maximizing the impact of prospective audit and feedback on total antibiotic use
por: Campbell, Tonya J., et al.
Publicado: (2017) -
Nirmatrelvir-ritonavir for COVID-19
por: McDonald, Emily G, et al.
Publicado: (2022) -
Nirmatrelvir and ritonavir for COVID-19
Publicado: (2022) -
Drug Interactions With a Short Course of Nirmatrelvir and Ritonavir: Prescribers and Patients Beware
por: Ratain, Mark J., et al.
Publicado: (2022)